Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD40.Pan.CoV Vaccine Booster Trial in Healthy Adults
NCT07113106Phase 2Active, not recruiting
- Sponsor
- ANRS
- Start
- Jun 2025
- Primary completion
- Oct 2026
- Modality
- Vaccines & Immunotherapeutics, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of CD40 Pan-CoV in coronavirus disease 2019 (COVID-19), sponsored by ANRS. Started Jun 2025; status: active, not recruiting.
02
Drugs
CD40 Pan-CoV
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT07113106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07113106.